標題: GNC(NYSE:GNC) 健安喜:全球最大保健食品連鎖店
strate414
同學




UID 69614
精華 0
積分 0
帖子 7
閱讀權限 99
註冊 2017-10-31
用戶註冊天數 206
用戶失蹤天數 6

114.36.238.132
發表於 2018-2-13 23:17  資料 私人訊息 
更詳細
https://www.prnewswire.com/news-releases/gnc-and-harbin-pharmaceutical-announce-300-million-strategic-investment-and-china-joint-venture-300597785.html
注資集團:Harbin Pharmaceutical Group Holding Co
旗下在大陸有兩家上市公司
哈藥股份:600664
人民同泰:600829
頂部
jay
同學




UID 63827
精華 0
積分 0
帖子 158
閱讀權限 99
註冊 2016-7-25
用戶註冊天數 669
用戶失蹤天數 7

59.127.247.235
發表於 2018-2-14 00:38  資料 私人訊息 
我的解讀不知道有沒有問題
GNC從去年起開始積極清償負債
此前GNC每年大約都可賺2億美元
目前GNC的負債應該是19.9億美元 去年年底GNC商譽減損導致公司整年度出現了 4.8億虧損
而今年看來GNC應該還是可以賺1億多,中國如果挹注3億美元協助GNC營運資金
並協助GNC拓展中國市場 那麼GNC將可持續減少負債,從中國增加的營收又可增加營業利益,股價上漲可自市場取得資金,加速減少負債
那麼 我在想
中資在打甚麼算盤? 難道僅只是出手相助 分取些營利?
或者已經鎖定其經營權?
有沒有可能是併購的開始?
頂部
Raimu
同學




UID 292
精華 0
積分 0
帖子 496
閱讀權限 99
註冊 2011-4-1
用戶註冊天數 2612
用戶失蹤天數 0

49.159.171.10
發表於 2018-2-14 00:44  資料 私人訊息 
印象中中資一直想買
只是GNC好像不想單賣中國業務
頂部
Salmon
同學




UID 2482
精華 0
積分 0
帖子 290
閱讀權限 99
註冊 2013-5-25
用戶註冊天數 1826
用戶失蹤天數 0

123.193.99.156
發表於 2018-3-1 22:54  資料 私人訊息 
債務延展了,怎麼無動於衷....

GNC Successfully Completes Amendment And Extension Of Term Loan FacilityAgreement Extends Maturity and Increases Financial Flexibility

Closing Satisfies Refinancing Condition in Securities Purchase Agreement with Hayao


NEWS PROVIDED BY
GNC Holdings, Inc.Feb 28, 2018, 16:09 ET

PITTSBURGH, Feb. 28, 2018 /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC) (the "Company") today announced that the term lenders under GNC Nutrition Centers, Inc.'s ("GNC Nutrition") credit agreement have approved the extension of the maturity date of the term loans held by such lenders by two years to March 2021, subject to certain conditions, in addition to certain other modifications to the credit agreement.


In addition, GNC Nutrition has cancelled its existing revolving credit facility, entered into a new $100 million ABL Revolver and a portion of the extended term loans have been exchanged for ABL FILO term loans which, together with certain newly funded ABL FILO term loans, equal $275 million in aggregate principal amount.  The ABL Revolver and ABL FILO loans mature in August 2022 and December 2022, respectively, subject to certain conditions.
The completion of the amendment and extension process satisfies a condition to closing of the previously announced approximately $300 million strategic investment in the Company by Harbin Pharmaceutical Group Holding Co., Ltd ("Hayao"). Both parties are continuing to work together to complete the transaction.
"This amendment improves our financial flexibility and is an important milestone as we work to complete our transaction with Hayao," said Ken Martindale, chief executive officer of GNC. "We are very pleased with the strong support we received from our term loan lenders.  We remain focused on continuing to enhance the customer experience and deliver innovative products as we drive improved financial performance and long-term value for our stakeholders."
About Us  
GNC Holdings, Inc. (NYSE: GNC) - Headquartered in Pittsburgh, PA - is a leading global specialty health, wellness and performance retailer.

GNC connects customers to their best selves by offering a premium assortment of heath, wellness and performance products, including protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized third-party brands.
GNC's diversified, multi-channel business model generates revenue from product sales through company-owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce and corporate partnerships. As of December 31, 2017, GNC had approximately 9,000 locations, of which approximately 6,700 retail locations are in the United States (including approximately 2,400 Rite Aid franchise store-within-a-store locations) and franchise operations in approximately 50 countries.
Additional Information About the Equity Investment and Where to Find It
This communication is being made in respect of the proposed transaction involving GNC and Hayao. A special stockholder meeting will be announced soon to obtain stockholder approval in connection with the proposed issuance of convertible perpetual preferred stock to Hayao. GNC expects to file with the Securities and Exchange Commission (the "SEC") a proxy statement and other relevant documents in connection with the proposed equity issuance. The definitive proxy statement will be sent or given to the shareholders of the Company and will contain important information about the proposed equity issuance and related matters. INVESTORS OF GNC ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT GNC, HAYAO AND THE PROPOSED EQUITY ISSUANCE. Investors may obtain a free copy of these materials (when they are available) and other documents filed by GNC with the SEC at the SEC's website at www.sec.gov, at GNC's website at www.gnc.com or by sending a written request to GNC at GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania 15222, Attention: Secretary.

Forward-Looking Statements   
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the Company's financial condition, results of operations and business that is not historical information. Forward-looking statements can be identified by the use of terminology such as "subject to," "believes," "anticipates," "plans," "expects," "intends," "estimates," "projects," "may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions, or by discussions regarding dividend, share repurchase plan, strategy and outlook. While GNC believes there is a reasonable basis for its expectations and beliefs, they are inherently uncertain. The Company may not realize its expectations and its beliefs may not prove correct. Many factors could affect future performance and cause actual results to differ materially from those matters expressed in or implied by forward-looking statements, including but not limited to (1) GNC may be unable to obtain stockholder approval as required for the equity issuance; (2) conditions to the closing of the transaction may not be satisfied and required regulatory approvals may not be obtained; (3) the transaction may involve unexpected costs, liabilities or delays; (4) the business of GNC may suffer as a result of uncertainty surrounding the transaction; (5) the outcome of any legal proceedings related to the transaction; (6) GNC may be adversely affected by other economic, business, legislative, regulatory and/or competitive factors; (7) the occurrence of any event, change or other circumstances that could give rise to the termination of the securities purchase agreement; or (8) other risks to consummation of the transaction, including the risk that the transaction will not be consummated within the expected time period or at all. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Actual results could differ materially from those described or implied by such forward-looking statements. For a listing of factors that may materially affect such forward-looking statements, please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2016.

This document will not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
Participants in Solicitation
The Company and its directors, executive officers and certain other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed equity issuance. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of the Company's stockholders in connection with the proposed equity issuance will be set forth in the Company's definitive proxy statement for its special stockholder meeting. Additional information regarding these individuals and any direct or indirect interests they may have in the proposed equity issuance will be set forth in the definitive proxy statement when and if it is filed with the SEC in connection with the proposed equity issuance.
頂部